Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Efficacy of primary preventive ICD therapy in an unselected population of patients with reduced left ventricular ejection fraction.

Sjöblom, J ; Kalm, T ; Gadler, F ; Ljung, L ; Frykman, V ; Rosenqvist, M ; Platonov, Pyotr LU and Borgquist, Rasmus LU orcid (2015) In Europace 17(2). p.255-261
Abstract
International guidelines advocate an implantable cardioverter and defibrillator (ICD) in patients with reduced left ventricular ejection fraction (LVEF) to prevent sudden death (SCD). Previous data suggest that the benefit of ICD therapy in real life may be lower than expected from the results of controlled studies and side-effects are not negligible. It is also unclear whether women benefit from treatment to the same extent as men. The aim of this study was to investigate the balance between benefits and complications of ICD therapy in a real-life population of patients with heart failure.
Please use this url to cite or link to this publication:
author
; ; ; ; ; ; and
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Europace
volume
17
issue
2
pages
255 - 261
publisher
Oxford University Press
external identifiers
  • pmid:25210024
  • wos:000351601600016
  • scopus:84922429729
  • pmid:25210024
ISSN
1532-2092
DOI
10.1093/europace/euu219
language
English
LU publication?
yes
id
9402d666-a079-469c-bd1f-0d9991ca9e9d (old id 4691859)
alternative location
http://www.ncbi.nlm.nih.gov/pubmed/25210024?dopt=Abstract
date added to LUP
2016-04-01 11:10:32
date last changed
2022-03-27 22:56:40
@article{9402d666-a079-469c-bd1f-0d9991ca9e9d,
  abstract     = {{International guidelines advocate an implantable cardioverter and defibrillator (ICD) in patients with reduced left ventricular ejection fraction (LVEF) to prevent sudden death (SCD). Previous data suggest that the benefit of ICD therapy in real life may be lower than expected from the results of controlled studies and side-effects are not negligible. It is also unclear whether women benefit from treatment to the same extent as men. The aim of this study was to investigate the balance between benefits and complications of ICD therapy in a real-life population of patients with heart failure.}},
  author       = {{Sjöblom, J and Kalm, T and Gadler, F and Ljung, L and Frykman, V and Rosenqvist, M and Platonov, Pyotr and Borgquist, Rasmus}},
  issn         = {{1532-2092}},
  language     = {{eng}},
  number       = {{2}},
  pages        = {{255--261}},
  publisher    = {{Oxford University Press}},
  series       = {{Europace}},
  title        = {{Efficacy of primary preventive ICD therapy in an unselected population of patients with reduced left ventricular ejection fraction.}},
  url          = {{https://lup.lub.lu.se/search/files/2438912/5336544.pdf}},
  doi          = {{10.1093/europace/euu219}},
  volume       = {{17}},
  year         = {{2015}},
}